Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Anthem Blue Cross and Blue Shield members will continue to receive in-network coverage within the Stamford Health system, ...

Over 66% of U.S. adults use at least one prescription drug, according to data gathered by the Health Policy Institute at ...

Heather Bryan was diagnosed with a rare form of blood cancer, for which she was prescribed Cotellic, a pill that slows the ...

Iowa lawmakers are advancing legislation supporters say would lower prescription drug prices and help prevent pharmacy ...

Philadelphia-based Independence Blue Cross has set a benefit exclusion for products that receive accelerated approval from ...

Donald Trump’s new administration has the opportunity to address a critical but little-known aspect of our country’s health ...

Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...

Eden Prairie-based health care giant blasts finding based on just Affordable Care Act plans; researchers note limitations with data.

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent increase from 2023, according to a Globe analysis of insurance claims data.

*Corresponding Author: Leif W. Ellisen, MGH Cancer Center, CPZN-4204, 185 Cambridge Street, Boston, MA 02114. E-mail: [email protected] Clin Cancer Res 2025;XX:XX ...

Blue Cross Blue Shield of Michigan is under new ... Much of the rising costs, at least for BCBSM, comes from the rise of specialty drugs. The Detroit-based insurer reported a $544 million ...